IntegraMed plans new debt financing for buyout by Sagard Capital

By Sara Rosenberg

New York, June 11 - IntegraMed America Inc. has received a debt commitment from GCI Capital Markets LLC and Sagard Capital Partners LP to help fund its acquisition by Sagard Capital Partners, according to an 8-K filed with the Securities and Exchange Commission on Monday.

Other funds for the $169.5 million buyout will come from equity.

Under the agreement, IntegraMed is being bought for $14.05 per share in cash.

Closing is expected no later than mid-November, subject to shareholder approval and other regulatory and customary conditions. The transaction is not subject to financing.

IntegraMed is a Purchase, N.Y.-based developer, marketer and manager of specialty healthcare facilities in the fertility and vein care markets.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.